Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02307513
Brief Title: A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behcet's Disease

First Submitted : December 2, 2014
First Submitted that Met QC Criteria : December 2, 2014
First Posted : December 4, 2014 (Estimate)

Certification/Extension First Submitted : January 10, 2018
Certification/Extension First Submitted that Met QC Criteria : January 10, 2018
Certification/Extension First Posted : January 16, 2018

Last Update Submitted that Met QC Criteria : March 28, 2019
Last Update Posted : April 2, 2019